Mealey's (May 8, 2019, 2:12 PM EDT) -- SAN FRANCISCO — A California federal judge on May 3 dismissed claims for false advertising against a list pricing company but held that a pharmaceutical company’s claims for violations of the Lanham Act, California's False Advertising Law and unfair competition laws against a laboratory in relation to its advertisement of a cocaine hydrochloride solution can proceed (Genus Lifesciences Inc. v. Lannett Company, Inc., et al., No. 18-cv-07603, N.D. Calif., 2019 U.S. Dist. LEXIS 76346)....